Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis.
Jamal AlamiriCameron J BrittonMohamed E AhmedJack R AndrewsJulianna L HigaAyca DundarR Jeffrey KarnesEugene KwonVal J LoweAyse T KendiMichael S BoldLance C PagliaroPublished in: The Prostate (2022)
Nearly 40% of mCRPC patients placed on SGA post docetaxel chemotherapy will exhibit paradoxical responses to therapy, therefore, warranting close follow up with imaging. C-11 choline PET/CT imaging is a useful tool that can help in early predication of disease progression or treatment failure.
Keyphrases
- pet ct
- prostate cancer
- end stage renal disease
- high resolution
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- small cell lung cancer
- newly diagnosed
- locally advanced
- positron emission tomography
- prognostic factors
- peritoneal dialysis
- stem cells
- computed tomography
- patient reported outcomes
- fluorescence imaging